NGVT Ingevity Corp

Price (delayed)

$69.53

Market cap

$2.58B

P/E Ratio

12.55

Dividend/share

N/A

EPS

$5.54

Enterprise value

$4.04B

Ingevity provides specialty chemicals, high-performance carbon materials and engineered polymers that purify, protect and enhance the world around us. Through a team of talented and experienced people, Ingevity develops, manufactures, ...

Highlights
NGVT's P/E is 31% below its 5-year quarterly average of 18.5 and 14% below its last 4 quarters average of 14.8
The company's revenue rose by 20% YoY and by 2.9% QoQ
The EPS has soared by 87% year-on-year but it is down by 5% since the previous quarter
NGVT's net income has soared by 79% YoY but it is down by 6% QoQ
The quick ratio has contracted by 39% YoY and by 10% from the previous quarter
The debt is up by 27% from the previous quarter and by 16% YoY

Key stats

What are the main financial stats of NGVT
Market
Shares outstanding
37.15M
Market cap
$2.58B
Enterprise value
$4.04B
Valuations
Price to earnings (P/E)
12.55
Price to book (P/B)
3.72
Price to sales (P/S)
1.56
EV/EBIT
12.18
EV/EBITDA
8.85
EV/Sales
2.42
Earnings
Revenue
$1.67B
EBIT
$331.4M
EBITDA
$456.3M
Free cash flow
$170.6M
Per share
EPS
$5.54
Free cash flow per share
$4.56
Book value per share
$18.69
Revenue per share
$44.64
TBVPS
$48.52
Balance sheet
Total assets
$2.74B
Total liabilities
$2.04B
Debt
$1.53B
Equity
$698.3M
Working capital
$375.5M
Liquidity
Debt to equity
2.19
Current ratio
2.24
Quick ratio
0.99
Net debt/EBITDA
3.19
Margins
EBITDA margin
27.4%
Gross margin
34.2%
Net margin
12.7%
Operating margin
19.3%
Efficiency
Return on assets
8.6%
Return on equity
31.7%
Return on invested capital
13%
Return on capital employed
13.6%
Return on sales
19.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NGVT stock price

How has the Ingevity stock price performed over time
Intraday
-1.18%
1 week
-4%
1 month
-21.04%
1 year
7.38%
YTD
-1.29%
QTD
-1.29%

Financial performance

How have Ingevity's revenue and profit performed over time
Revenue
$1.67B
Gross profit
$570.1M
Operating income
$322.2M
Net income
$211.6M
Gross margin
34.2%
Net margin
12.7%
NGVT's net income has soared by 79% YoY but it is down by 6% QoQ
The net margin is up by 49% YoY but it is down by 9% from the previous quarter
The company's revenue rose by 20% YoY and by 2.9% QoQ
Ingevity's operating income has increased by 11% YoY but it has decreased by 3% from the previous quarter

Growth

What is Ingevity's growth rate over time

Valuation

What is Ingevity stock price valuation
P/E
12.55
P/B
3.72
P/S
1.56
EV/EBIT
12.18
EV/EBITDA
8.85
EV/Sales
2.42
The EPS has soared by 87% year-on-year but it is down by 5% since the previous quarter
NGVT's P/E is 31% below its 5-year quarterly average of 18.5 and 14% below its last 4 quarters average of 14.8
The P/B is 42% below the 5-year quarterly average of 6.5
The equity has grown by 10% from the previous quarter and by 3.6% YoY
NGVT's P/S is 34% below its 5-year quarterly average of 2.4
The company's revenue rose by 20% YoY and by 2.9% QoQ

Efficiency

How efficient is Ingevity business performance
The ROE has soared by 79% year-on-year but it has declined by 7% since the previous quarter
The ROA has soared by 76% YoY but it has contracted by 9% from the previous quarter
Ingevity's ROIC has increased by 48% YoY but it has decreased by 7% from the previous quarter
The ROS is up by 29% year-on-year but it is down by 4.8% since the previous quarter

Dividends

What is NGVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NGVT.

Financial health

How did Ingevity financials performed over time
The total assets is 34% greater than the total liabilities
The quick ratio has contracted by 39% YoY and by 10% from the previous quarter
NGVT's total liabilities is up by 20% since the previous quarter and by 14% year-on-year
The debt is 119% more than the equity
The debt is up by 27% from the previous quarter and by 16% YoY
Ingevity's debt to equity has increased by 15% from the previous quarter and by 12% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.